Announcement on Voluntary Disclosure of Obtaining Approval Notice for 2 Phase II/III Drug Clinical Trials of iza-bren (EGFR×HER3 Dual-antibody ADC) Combination Therapy in the Treatment of Advanced or Extensive-stage Solid Tumors
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment